James J Whitehead,
Researcher Getting alot Better
40 A Josephine Avenue London SW2 2LA
Send response to journal:
Dear Nicholas Bennett and everyone else,
I have been pondering on a few puzzles I have regarding "immunosuppression"- CD4 levels in relation to HHV-8 incidence and the incidence of Kaposi Sarcoma within various geographical areas or "risk- groups" and I wondered if anyone from any "side" could please answer the following questions for me. I would be most greatfull if anyone from any "side" could provide me with any references/studies/answers to my questions.
1.What is the average CD4 in post operative kidney transplant recipients on "immunosuppressive therapies" ?
2. What is the average CD4 in post transplant liver transplant recipients on "immunosuppresive therapies" ?
3.Is there any evidence/references/studies that show any geographical differences in the level of "immunosuppression"-CD4 occuring in organ transplants recipients on "immunosuppressive" therapies ?
4. Am I right in thinking that currentley it is claimed/believed that the differences in geograpical rates of Kaposi Sarcoma occuring in organ transplant recipients is due to the background incidence/seroprevelance of HHV-8 ?
5.Am I right in thinking that currentley it is claimed/believed that the differences in geographical and "risk-group" rates of occurance of aids type KS is due to the background incidence/seroprevelance of HHV-8 ?
Thank you in advance.
James J Whitehead
Clinical trials volunteer
Member www.altheal.org and www.aidsmythexposed.com
Competing interests: Clinical trials volunteer Member www.altheal.org